Breast Cancer Screening in the Intermediate-Risk Population: Falling Through the Cracks?
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data
PubMed 38420877 · doi:10.1177/08465371241234544
What was done
This narrative review examined breast cancer screening guidelines and risk assessment tools for women at intermediate risk of developing breast cancer (defined as a 15% to 20% lifetime risk).
What was found
The abstract reports no numerical data or empirical findings. It notes that screening guidelines vary across jurisdictions for women at intermediate risk and that currently available risk assessment models have differing strengths and weaknesses, leading to ambiguity in model selection.
Why it matters
It highlights a clinical grey area where intermediate-risk women face inconsistent screening recommendations and uncertain risk-tool selection.
Limits
The abstract describes a narrative review without primary data, systematic search parameters, sample size, or quantitative comparisons.
Cited by
- supports Breast cancer risk models categorize low risk as less than 15%, intermediate risk as 15% to 20%, and high risk as 20% or greater lifetime risk.